Metropolitan Life Insurance CO Avidity Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$10.62 - $17.34 $3,589 - $5,860	338 Added 9.57%	3,869 $42,000
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $3,377 - $5,643	220 Added 6.64%	3,531 $54,000
Q4 2022 Jun 14, 2023	SELL	$10.06 - $22.66 $2,213 - $4,985	-220 Reduced 6.23%	3,311 $73.5 Million
Q4 2022 Mar 30, 2023	BUY	$10.06 - $22.66 $3,410 - $7,681	339 Added 11.41%	3,311 $73,000
Q4 2022 Feb 15, 2023	BUY	$10.06 - $22.66 $3,410 - $7,681	339 Added 11.41%	3,311 $73,000
Q3 2022 Jun 14, 2023	SELL	$15.46 - $23.43 $8,642 - $13,097	-559 Reduced 15.83%	2,972 $48.5 Million
Q2 2022 Jun 20, 2023	SELL	$11.18 - $20.5 $6,249 - $11,459	-559 Reduced 15.83%	2,972 $43,000
Q2 2022 Mar 30, 2023	BUY	$11.18 - $20.5 $8,541 - $15,662	764 Added 34.6%	2,972 $43,000
Q2 2022 Aug 11, 2022	BUY	$11.18 - $20.5 $8,541 - $15,662	764 Added 34.6%	2,972 $43,000
Q1 2022 Jun 20, 2023	SELL	$14.2 - $23.78 $18,786 - $31,460	-1,323 Reduced 37.47%	2,208 $40,000
Q1 2022 Mar 30, 2023	SELL	$14.2 - $23.78 $101,686 - $170,288	-7,161 Reduced 76.43%	2,208 $40,000
Q1 2022 May 12, 2022	SELL	$14.2 - $23.78 $101,686 - $170,288	-7,161 Reduced 76.43%	2,208 $41,000
Q4 2021 Jun 21, 2023	BUY	$20.4 - $28.66 $119,095 - $167,317	5,838 Added 165.34%	9,369 $222,000
Q3 2021 Jun 21, 2023	BUY	$18.16 - $25.21 $106,018 - $147,175	5,838 Added 165.34%	9,369 $230,000
Q2 2021 Jun 21, 2023	BUY	$19.62 - $29.26 $114,541 - $170,819	5,838 Added 165.34%	9,369 $231,000
Q2 2021 Mar 30, 2023	BUY	$19.62 - $29.26 $8,260 - $12,318	421 Added 4.7%	9,369 $231,000
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $183,643 - $273,873	9,360 Added 104000.0%	9,369 $232,000
Q1 2021 Jun 26, 2023	BUY	$20.28 - $28.15 $109,856 - $152,488	5,417 Added 153.41%	8,948 $195 Million
Q1 2021 Mar 30, 2023	BUY	$20.28 - $28.15 $78,503 - $108,968	3,871 Added 76.25%	8,948 $195,000
Q1 2021 May 14, 2021	SELL	$20.28 - $28.15 $102,779 - $142,664	-5,068 Reduced 99.82%	9 $195,000
Q4 2020 Jun 22, 2023	BUY	$24.73 - $35.12 $38,232 - $54,295	1,546 Added 43.78%	5,077 $129,000
Q3 2020 Jun 26, 2023	BUY	$23.35 - $35.94 $36,099 - $55,563	1,546 Added 43.78%	5,077 $142,000
Q3 2020 Mar 30, 2023	BUY	$23.35 - $35.94 $41,236 - $63,470	1,766 Added 53.34%	5,077 $142,000
Q3 2020 Nov 13, 2020	BUY	$23.35 - $35.94 $118,547 - $182,467	5,077 New	5,077 $143,000

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

Price T Rowe Associates Inc Baltimore, MD

10.6M
Shares

$460 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

9.23M
Shares

$399 Million
0.01% of portfolio
Black Rock Inc. New York, NY

8.62M
Shares

$373 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

8.13M
Shares

$352 Million
5.95% of portfolio
Wellington Management Group LLP Boston, MA

7.03M
Shares

$304 Million
0.06% of portfolio

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.25B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account